InxMed doses first patient in cancer trial of IN10018
Metastatic uveal melanoma, which affects the eye, has no approved medicines to date. Credit: Vanessa Bumbeers on Unsplash.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
